Iovance Biotherapeutics, Inc. ( IOVA) - Key Metrics
IOVA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.22 | -$0.11 | -$0.14 | -$0.15 |
| 2026Q1 | $0.17 | -$0.19 | -$0.17 | -$0.19 |
| 2025Q4 | $0.21 | -$0.18 | -$0.13 | -$0.15 |
| 2025Q3 | $0.19 | -$0.25 | -$0.22 | -$0.25 |
| 2025Q2 | $0.18 | -$0.33 | -$0.20 | -$0.22 |
IOVA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -9.45 |
| 2026Q1 | 0% | -4.62 |
| 2025Q4 | 0% | -4.55 |
| 2025Q3 | 0% | -2.17 |
| 2025Q2 | 0% | -1.30 |
IOVA
Price: $6.98
52 week price:
Earnings Per Share: -0.69 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 3.5 million
Ebitda: -22.1 millionMarket Capitalization: 3.1 billion